No Photo Available

Last Update

2017-01-30T00:00:00.000Z

This profile was last updated on .

Is this you? Claim your profile.

Wrong Pamela Hay?

Dr. Pamela A. Hay

Senior Vice President of Corporate Development

Dyax Corp.

HQ Phone: (617) 225-2500

Get ZoomInfo Grow

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Grow at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

Dyax Corp.

55 Network Drive

Burlington, Massachusetts 01803

United States

Company Description

Dyax is a biopharmaceutical company focused on the development and commercialization of novel biotherapeutics for unmet medical needs. Dyax is developing DX-2930, a fully human monoclonal antibody, for the prevention of HAE attacks. Additionally, Dyax mar ... more

Find other employees at this company (183)

Background Information

Employment History

Chief Commercial Officer

Domantis Limited

Senior Legal Positions

Biogen Idec Inc.

Senior Legal Positions

T Cell Sciences

Co-Founder and President

Visgo

Partner

Red Sky Partners, LLC.

Consultant

Biotechnology Business Strategy Consulting

General Counsel

AVANT Immunotherapeutics , Inc.

Affiliations

Advisor
NeuroHealing Pharmaceuticals Inc

Education

B.A.

Biology

Cornell University

J.D.

Biology

University of Wisconsin Law School

Ms Hay

Dyax Corp.

Ms Hay

T Cell Sciences and Corporate Counsel

Web References (24 Total References)


Pamela Hay, ...

www.neurohealing.com [cached]

Pamela Hay, J.D.

Pamela Hay is a business development and operations consultant for early stage biotechnology companies. She was Chief Commercial Officer at Domantis Ltd from 2001 until its acquisition by GSK in 2007, where she oversaw commercial development, including completion of major alliances with Abbott and BMS and additional deal negotiations that concluded the company purchase. Previously, she was SVP, Corporate Development at Dyax Corp where she was responsible for the negotiation of more than 60 licenses and collaborations as well as the legal and IP functions. She has also held senior legal positions at T Cell Sciences and Biogen. Pamela has a JD from the University of Wisconsin and a BA in Biology from Cornell University.


NeuroHealing Pharmaceuticals Inc.

www.neurohealing.com [cached]

Pamela Hay, J.D.

...
Pamela Hay, J.D. Pamela Hay is a business development and operations consultant for early stage biotechnology companies. She was Chief Commercial Officer at Domantis Ltd from 2001 until its acquisition by GSK in 2007, where she oversaw commercial development, including completion of major alliances with Abbott and BMS and additional deal negotiations that concluded the companys purchase. Previously, she was SVP, Corporate Development at Dyax Corp where she was responsible for the negotiation of more than 60 licenses and collaborations as well as the legal and IP functions. She has also held senior legal positions at T Cell Sciences and Biogen. Pamela has a JD from the University of Wisconsin and a BA in Biology from Cornell University.


News & Headlines: Diversys Names Pamela Hay Chief Commercial Officer

www.otohns.net [cached]

2001 NOV 12 - (NewsRx.com & NewsRx.net) -- Diversys Ltd., a protein engineering company, has hired business development executive Pamela Hay as chief commercial officer. Ms. Hay is considered an expert in the developing business opportunities in the fields of protein repertoires and protein engineering, and is a prolific negotiator of deals in this sector, according to the company.

...
Ms. Hay has more than 15 years of legal and business development experience with major biotechnology and pharmaceutical companies. With a degree in biology from Cornell and a law degree from the University of Wisconsin. She joined Dyax Corp. in 1996, where she rose to become senior vice president of corporate development and strategic opportunities. Within Dyax, Ms. Hay and her team negotiated over 75 collaboration, technology transfer and license agreements involving the company's phage display technology and product leads, managed the company's growing patent portfolio and legal needs, and helped lead the acquisition of new technologies. Ms. Hay will assume responsibility for the commercialization of Diversys' protein repertoire and engineering technologies for therapeutic, diagnostic and research use. In addition, she will be in charge of business development activities and management of Diversys intellectual property portfolio. Ms. Hay will be based in Diversys' new commercial office in Cambridge, Massachusetts. This article was prepared by Health & Medicine Week editors from staff and other reports.


NeuroHealing Pharmaceuticals Inc.

www.NHpharma.com [cached]

Pamela Hay, J.D.

...
Pamela Hay, J.D. Pamela Hay is a business development and operations consultant for early stage biotechnology companies. She was Chief Commercial Officer at Domantis Ltd from 2001 until its acquisition by GSK in 2007, where she oversaw commercial development, including completion of major alliances with Abbott and BMS and additional deal negotiations that concluded the company's purchase. Previously, she was SVP, Corporate Development at Dyax Corp where she was responsible for the negotiation of more than 60 licenses and collaborations as well as the legal and IP functions. She has also held senior legal positions at T Cell Sciences and Biogen. Pamela has a JD from the University of Wisconsin and a BA in Biology from Cornell University.


Domantis

www.domantis.com [cached]

Pamela Hay - Chief Commercial Officer

Prior to joining Domantis, Ms Hay was SVP, Corporate Development and Strategic Opportunities at Dyax Corp., a public biotechnology company which utilizes phage display to discover novel therapeutic, diagnostic and separation products.Before Dyax, Ms Hay was General Counsel at T Cell Sciences (now Avant Immunotherapeutics) and Corporate Counsel at Biogen Inc.

Similar Profiles

Other People with this Name

Other people with the name Hay

Petrice Hay
Go Groopie

Marcus Hay
Air Flite Inc

Jason Hay
Fort Street Advisers Pty Ltd

Jane Hay
Auckland Theatre Company

Andrew Hay
Mossop Group Pty Ltd

City Directory Icon

Browse ZoomInfo's Business Contact Directory by City

People Directory Icon

Browse ZoomInfo's
Business People Directory

Company Directory Icon

Browse ZoomInfo's
Advanced Company Directory